Ozempic and Wegovy don’t cost what you think they do

New York Times

22 October 2023 - Drug companies are making billions from a new class of in demand weight loss treatments. But the prices are not what they seem.

The problem is daunting: powerful but expensive new drugs could help many of the 100 million American adults who have obesity and alleviate a grave public health concern.

Read New York Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing